Skip to main content
CRL logo

CRL · Charles River Laboratories International, Inc.

Track CRL — free
$280.05 -1.22 (-0.43%) At close · Aug 14
Market Cap
$13.37B
Shares
47.74M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$1,000,000,000
as of 2025-10-29 · from 8-K (reviewed)
Remaining Authorization
$700,000,000
as of 2026-06-27
Program Utilization
30.0% $300,000,000 used of $1,000,000,000
Program Announced Authorized Remaining Runs Through
2025-10-29 $1,000,000,000 $700,000,000

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-06-27 YTD $323,881,000
2025-12-27 $360,673,000
2024-12-28 $119,175,000
2023-12-30 $24,155,000
2022-12-31 $38,651,000
2021-12-25 $40,707,000
2020-12-26 $23,979,000
2019-12-28 $18,087,000
2018-12-29 $13,846,000
2017-12-30 $106,909,000
2016-12-31 $12,267,000
2015-12-26 $117,478,000
2014-12-27 $122,018,000
2013-12-28 $165,932,000
2012-12-29 $64,189,000
2011-12-31 $283,795,000
2010-12-25 $356,527,000
2009-12-26 $45,897,000
2008-12-27 $115,058,000
Key facts CIK 1100682 CUSIP 159864107 13F (30d) 534 filings 508 filers Visit website Investor relations